Izicopan

N/A

Report date: 2026/02/27 20:01:47
NME

Base Information

Drug NameIzicopan
Drug Alias NameINF904INF-904
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsInflammationAutoimmune DiseasesHidradenitis +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesPoland +[6
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInflarx Nv
China Registration ClassN/A

Develop Information

Active CompaniesInflarx Nv
Inactive CompaniesInflarx Gmbh
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsHidradenitisChronic UrticariaHidradenitis Suppurativa

Other Information

ATC CodeN/A
Related LinksN/A